InvestorsHub Logo
Followers 43
Posts 4253
Boards Moderated 0
Alias Born 07/14/2010

Re: None

Tuesday, 09/05/2017 9:18:17 AM

Tuesday, September 05, 2017 9:18:17 AM

Post# of 549
They have more institutional buyers buying in regularly.

https://theolympiareport.com/2017/08/28/schwab-charles-investment-management-inc-increases-stake-in-otonomy-inc-otic.html

http://www.firstnewspaper24.com/2017/08/otonomy-inc-otic-position-increased-by-jennison-associates-llc-last-quarter/

Wellington Management Group LLP increased its position in Otonomy by 28.9% in the first quarter. Wellington Management Group LLP now owns 4,211,357 shares of the biopharmaceutical company’s stock worth $51,590,000 after buying an additional 944,663 shares during the period. Point72 Asset Management L.P. bought a new position in Otonomy during the first quarter worth approximately $7,355,000. JPMorgan Chase & Co. increased its position in Otonomy by 10,065.2% in the second quarter. JPMorgan Chase & Co. now owns 517,410 shares of the biopharmaceutical company’s stock worth $9,753,000 after buying an additional 512,320 shares during the period. Schroder Investment Management Group increased its position in Otonomy by 37.5% in the first quarter. Schroder Investment Management Group now owns 763,368 shares of the biopharmaceutical company’s stock worth $9,351,000 after buying an additional 208,221 shares during the period. Finally, Kingdon Capital Management L.L.C. increased its position in Otonomy by 27.9% in the first quarter. Kingdon Capital Management L.L.C. now owns 773,693 shares of the biopharmaceutical company’s stock worth $9,478,000 after buying an additional 168,833 shares during the period. 88.74% of the stock is owned by institutional investors and hedge funds.

California State Teachers Retirement System raised its position in Otonomy by 5.7% in the second quarter. California State Teachers Retirement System now owns 49,993 shares of the biopharmaceutical company’s stock valued at $942,000 after buying an additional 2,700 shares in the last quarter. The Manufacturers Life Insurance Company raised its position in Otonomy by 13.7% in the second quarter. The Manufacturers Life Insurance Company now owns 23,105 shares of the biopharmaceutical company’s stock valued at $435,000 after buying an additional 2,776 shares in the last quarter. Voya Investment Management LLC raised its position in Otonomy by 17.9% in the second quarter. Voya Investment Management LLC now owns 12,606 shares of the biopharmaceutical company’s stock valued at $238,000 after buying an additional 1,918 shares in the last quarter. Dimensional Fund Advisors LP raised its position in Otonomy by 31.1% in the second quarter. Dimensional Fund Advisors LP now owns 407,799 shares of the biopharmaceutical company’s stock valued at $7,687,000 after buying an additional 96,630 shares in the last quarter. Finally, Northern Trust Corp raised its position in Otonomy by 16.9% in the second quarter. Northern Trust Corp now owns 348,514 shares of the biopharmaceutical company’s stock valued at $6,570,000 after buying an additional 50,261 shares in the last quarter. 88.74% of the stock is owned by hedge funds and other institutional investors.

Vanguard Group Inc. boosted its stake in Otonomy, Inc. Swiss National Bank now owns 34,800 shares of the biopharmaceutical company's stock worth $426,000

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.